|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 489/12 | |
| A61K 31/439 | |||
| A61P 25/30 |
| (11) | Number of the document | 2552924 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11715634.9 |
| Date of filing the European patent application | 2011-04-04 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/031130 |
| Date | 2011-04-04 |
| (87) | Number | WO 2011/123863 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 320514 P | 2010-04-02 | US | |
| 320522 P | 2010-04-02 | US |
| (72) |
STINCHCOMB, Audra, Lynn, US
LI, Guohua, US
BANKS, Stan, Lee, US
HOWARD, Jeffery, Lynn, US
GOLINSKI, Miroslaw, Jerzy, US
|
| (73) |
Zynerba Pharmaceuticals, Inc.,
80 W. Lancaster Avenue Suite 300, Devon, PA 19333,
US
|
| (54) | TRANSDERMALLY DELIVERABLE OPIOID PRODRUGS, ABUSE-RESISTANT COMPOSITIONS AND METHODS OF USING OPIOID PRODRUGS |
| TRANSDERMALLY DELIVERABLE OPIOID PRODRUGS, ABUSE-RESISTANT COMPOSITIONS AND METHODS OF USING OPIOID PRODRUGS |